Importation Of Italian-authorized Bupisen Iperbarica 7,5 Mg/ml Soluzione Iniettabile (bupivacaine Hydrochloride In Dextrose Injection) Due To The Current Shortage Of Canadian-authorized Bupivacaine Hy

Recall Summary Health Canada is recalling BUPISEN iperbarica 7.5 mg/ml injection (a local anesthetic containing bupivacaine) that was imported from Italy due to concerns about product safety, supply issues, and labelling. The product was distributed across Canada. This recall was issued because of a shortage of Canadian-authorized bupivacaine products.

Product
BUPISEN iperbarica 7,5 mg/ml soluzione iniettabile
Reason
Product safety - Supply - Labelling
Category
drug recall
Country
Canada
Agency
HC-DRUGS
Recall date
2026-11-19
Status
Ongoing
Distribution
Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/b2acaf3d-700a-4e0d-a9f9-6533e32c86cd